Close menu




 

Fabian Lorenz

  • Small-Caps
  • Micro-Caps

For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.

Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.


Commented by Fabian Lorenz

Commented by Fabian Lorenz on August 31st, 2023 | 08:30 CEST

Is the breakthrough coming? BYD, Plug Power, dynaCERT share in check

  • greenhydrogen
  • Hydrogen
  • Electromobility

Shares related to the energy and mobility transition have not had it easy in recent months. But will the autumn bring a liberation blow? The negative sentiment could be a good contraindicator. BYD recently published convincing figures. However, analysts foresee fierce competition in the coming years. Plug Power has recently seen its price targets plummet. Does that mean the worst is behind us? At dynaCERT, the AEM electrolyser for green hydrogen is becoming a big seller. More and more industrial companies are testing it. Now, green hydrogen is also expected to contribute to green steel production in Canada.

Read

Commented by Fabian Lorenz on August 30th, 2023 | 08:30 CEST

Better than Nel & Co.? Megatrend shares Redcare Pharmacy and Cantourage Group recommended as buy

  • Cannabis
  • megatrend
  • Pharma

Hydrogen has electrified investors for years. But pure-plays like Plug Power and Nel & Co. are struggling to get their numbers in order and are far from profitable business models. As a result, these shares are not much fun at the moment, and analysts see further downside potential. In such a situation, it is worth taking a look at other megatrend stocks. Redcare Pharmacy (formerly Shop Apotheke) is benefiting from online pharmacy and e-prescription trends. The share has already more than doubled this year. Investors can profit from the cannabis trend with the German Cantourage Group. The Company is growing strongly and the share price has come to rest (before the storm). Both shares are recommended to buy by analysts.

Read

Commented by Fabian Lorenz on August 23rd, 2023 | 09:10 CEST

Disappointments and surprises: Nikola, Plug Power, First Hydrogen

  • Hydrogen
  • greenhydrogen
  • renewableenergies

Hydrogen and electromobility are megatrends. But not all shares from these sectors deliver what they promise. Nikola has recently disappointed. After the share price multiplied in June and July, it halved in August. And now Nikola has shocked shareholders again. Investors have also been unhappy with Plug Power in recent months. The hydrogen specialist just cannot get a handle on its margins. Is there hope for both again after the recent sell-offs? In contrast, First Hydrogen has surprised on the upside. A customer is enthusiastic about the test of the hydrogen fuel cell vehicle. Will a major order follow now, along with a rediscovery of the stock?

Read

Commented by Fabian Lorenz on August 17th, 2023 | 08:30 CEST

Plug Power, JinkoSolar, Altech Advanced Materials: Only one share is strong

  • Technology
  • renewableenergies
  • Energy

The stock market is currently on shaky ground. In such times, it is worth considering stocks that show relative strength. Which renewable energy company falls into this category? Hydrogen specialist Plug Power disappointed again with its latest quarterly figures. And now analysts are also losing patience. In contrast, JinkoSolar has increased its half-year profit by over 300%. However, the shares of the Chinese solar group are trading lower than they have in a long time. The shares of Altech Advanced Materials - also listed on XETRA since July - are among the German stock market stars of 2023 with a plus of 250%. But is there more in store? After all, the Company aims to revolutionize the battery market and even outshine the new Tesla battery.

Read

Commented by Fabian Lorenz on August 16th, 2023 | 05:35 CEST

BYD, Nel ASA and First Phosphate: These shares promise excitement!

  • Mining
  • phosphate
  • Electromobility
  • renewableenergies

Tension at BYD. Competitor Tesla continues to turn the price screw in China, and there is a surprise in the future topic of autonomous driving. Do the Chinese really not believe in technology in which other companies are investing billions? BYD, on the other hand, is going full throttle with its global expansion and presents a new vehicle. The latest news from First Phosphate also makes for exciting reading. The economic evaluation of the project for the extraction and processing of phosphate for the production of lithium-iron-phosphate batteries has resulted in a capital value of CAD 795 million. This compares with a market capitalization of about CAD 18 million. Nel ASA still brings EUR 1.8 billion to the stock exchange scales. Analysts do not see any upside potential for the Norwegian company.

Read

Commented by Fabian Lorenz on August 10th, 2023 | 08:00 CEST

Caution with Nikola share! Are Vonovia and Desert Gold bargains?

  • Mining
  • Gold
  • RealEstate

Hype stock or bargain? The Nikola share is undoubtedly one of the stock market stars of recent months. Within two months, the share has multiplied to EUR 3. Now, it has crashed to EUR 2. Is the hype over? Caution is advised. The Company is running out of capital, and the boss is jumping ship. In contrast, shares such as Desert Gold and Vonovia are at rock bottom. However, the gold explorer is a real bargain. Could the stock rise now? Analysts also see significant upside potential for Vonovia. Despite this, the DAX-listed group has had to make massive write-downs on its real estate portfolio. Where is the rise worthwhile now?

Read

Commented by Fabian Lorenz on August 9th, 2023 | 07:00 CEST

After BioNTech shock: Evotec, Morphosys and Cardiol Therapeutics emerge as the new biotech favorites

  • Biotechnology

BioNTech startled investors and analysts with its quarterly figures on Monday. Yet the biotech segment has actually developed positively in recent months. Several stocks are currently going full throttle, and S&P's sector index also outperformed the S&P 500 and MSCI World in July. This could finally signal the end of the underperformance of recent years, and biotech stocks could be celebrating a comeback. On the German stock charts, Evotec and Morphosys are among the high flyers. Both shares have performed strongly since April. Cardiol Therapeutics also looks promising from a technical chart perspective, and analysts see a price potential of over 200%. In contrast, there is currently no reason to buy BioNTech. Instead, investors should also bet on strength.

Read

Commented by Fabian Lorenz on August 3rd, 2023 | 08:30 CEST

CleanTech stocks about to rally? Standard Lithium, FREYR Battery, RegenX Tech Corp.

  • Mining
  • Lithium
  • Batteries
  • BatteryMetals
  • recycling

FREYR Battery could break out of its sideways trend next week. On August 10, the Company will report on its performance in the second quarter. Analysts see significant upside potential. At Regenx, too, there are many indications of an exciting second half. The first recycling plant for the extraction of platinum and palladium is currently being ramped up. In addition, the Company intends to earn money from emission certificates in the future. Tension is also rising at Standard Lithium. When will the feasibility study for the Arkansas project be completed, and will Germany's Lanxess then move to strike?

Read

Commented by Fabian Lorenz on August 2nd, 2023 | 09:55 CEST

Nikola Motors share unstoppable: Strong news also from BASF and Manuka Resources

  • Mining
  • Batteries
  • BatteryMetals
  • Electromobility
  • Vanadium

Forget about a recession. These stocks are on the fast track or the verge of a breakout. For example, the Nikola share gained more than 15% in value yesterday. The reason was a new order in the US. This means that the shares of the manufacturer of zero-emission trucks have multiplied within two months. The Manuka Resources share could also be on the verge of a breakout. Due to the ramped-up gold production, exploration activities are expected to be financed through the next three years. An added kicker for the Australians could be their involvement in battery raw materials. As for BASF, the recent profit warning hardly affected them. Analysts express positivity, but the possibility of a dividend cut remains on the table.

Read

Commented by Fabian Lorenz on July 27th, 2023 | 08:05 CEST

Plenty of upside potential: Plug Power, Standard Lithium, Defense Metals

  • Mining
  • RareEarths
  • Lithium
  • renewableenergies

After Nel ASA exceeded sales expectations in the second quarter, Goldman Sachs recommended the stock as a buy. The price target is NOK 20, offering almost 50% upside potential. Now Plug Power is also recommended as a buy, and analysts see a significantly higher price potential. Experts see nearly 200% price potential for Standard Lithium after the Company published convincing drilling results. Not yet on the screen of analysts is Defense Metals. But this could change soon. The Company is developing an exciting rare earths project in North America, and the preliminary economic valuation of over CAD 500 million gives the stock plenty of upside.

Read